Annovis Bio (ANVS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec3

Annovis Bio to Present Third-Stage Data on Parkinson's Dementia at Annual Meeting

13:01

Nov13

Annovis Bio released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -1.0099

04:00

Annovis Bio released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3699 (forecast USD -0.3766)

04:00

Nov7

Maxim Group Analyst Jason McCarthy Maintains Buy Rating on Annovis Bio

18:12

Oct14

Annovis Bio Inc. Issues Ordinary Shares to Raise $6 Million

21:20

Oct9

Annovis Bio Inc.'s Drug Buntanetap Shows Positive Biomarker Data in Alzheimer's Research

11:30

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.263 M, EPS -0.3699

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.22 M, EPS -0.32

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.537 M, EPS -0.32

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change